Finançament
Investigador/a: Aintzane Zabaleta Azpiroz
10 finançaments 1.069.932,00 €
2025
2021
2020
2019
-
Evaluation of the therapeutic efficacy of a compound in MM
120.300,00 €
-
Amyloidosis antibodies project
19.384,00 €
-
MECHANISM OF ACTION ANTI-CD38 IN MM AND AML
91.200,00 €
-
Evaluation of TriNKET in BMA samples from MM patients
96.600,00 €
-
Fibroblast Activation Factor (FAP) in Amyloidosis and MM
103.260,00 €